Retraction
Effectiveness of Ivermectin-Based Multidrug Therapy in Severely Hypoxic, Ambulatory COVID-19 Patients
Paper Information
Record ID:
60298
Author(s):
Journal:
Publication Date:
February 09, 2022
Retraction Date:
January 09, 2025
(<1 year years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
Countries:
Article Type:
Publisher:
Taylor and Francis
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1080/17460913.2025.2451540Citations (28)
28
Total Citations1
Post-Retraction(3.6%)
27
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
0
After 2+ years
143
Days since retraction (latest)
Ivermectin and COVID-19
Christopher C Butler, Richard Hobbs, Paul Little et al. (7 authors)
Journal of Infection
Open Access
Published: Jun 2025
143 days after retraction
Back to the Basics of SARS-CoV-2 Biochemistry: Microvascular Occlusive Glycan Bindings Govern Its Morbidities and Inform Therapeutic Responses
David Scheim, Peter Parry, David J. Rabbolini et al. (8 authors)
Viruses
Open Access
Published: Apr 2024
1 citation
1 citation
262 days before retraction
Back to the Basics of SARS-CoV-2 Biochemistry: Microvascular Occlusive Glycan Bindings Govern its Morbidities and Inform Therapeutic Responses. ADDENDUM
David Scheim, Peter Parry, David J. Rabbolini et al. (8 authors)
Unknown Journal
Open Access
Published: Apr 2024
4 citations
4 citations
264 days before retraction
Ivermectin for treatment of COVID-19: A systematic review and meta-analysis
Zhilong Song, Senyuan Shi, Yongli Zhang
Heliyon
Open Access
Published: Mar 2024
8 citations
8 citations
314 days before retraction
Wheel Replacing Pyramid: Better Paradigm Representing Totality of Evidence-Based Medicine
Colleen Aldous, Barry M. Dancis, Jerome Dancis et al. (4 authors)
Annals of Global Health
Open Access
Published: Jan 2024
2 citations
2 citations
374 days before retraction
Sialylated Glycan Bindings from SARS-CoV-2 Spike Protein to Blood and Endothelial Cells Govern the Severe Morbidities of COVID-19
David Scheim, Paola Vottero, Alessandro D. Santin et al. (4 authors)
International Journal of Molecular Sciences
Open Access
Published: Dec 2023
12 citations
12 citations
405 days before retraction
Interactions between the principal risk factors for reduction of the eGFR in unvaccinated COVID‑19 survivors: Normal pre-COVID‑19 eGFR, not having diabetes and being hospitalized
José Guzmán-Esquivel, Janet Diaz‐Martinez, Jose G. Ortega-Ortiz et al. (14 authors)
Experimental and Therapeutic Medicine
Open Access
Published: Oct 2023
1 citation
1 citation
437 days before retraction
Role of micronutrients in the modulation of immune system and platelet activating factor in patients with COVID-19; a narrative review
Saeid Doaei, Afrouz Mardi, Maryam Zare
Frontiers in Nutrition
Open Access
Published: Sep 2023
8 citations
8 citations
482 days before retraction
Management of onchocerciasis among adolescents in nkwanta north district of Ghana: Qualitative study of adolescents’ perception, community and health system support
Sitsofe Gbogbo, Hubert Amu, Robert Kokou Dowou et al. (4 authors)
PLoS neglected tropical diseases
Open Access
Published: Aug 2023
1 citation
1 citation
499 days before retraction
COVID-19 Excess Deaths in Peru’s 25 States in 2020: Nationwide Trends, Confounding Factors, and Correlations With the Extent of Ivermectin Treatment by State
Juan J Chamie, Jennifer A Hibberd, David Scheim
Cureus
Open Access
Published: Aug 2023
6 citations
6 citations
520 days before retraction
When Characteristics of Clinical Trials Require Per-Protocol as Well as Intention-to-Treat Outcomes to Draw Reliable Conclusions: Three Examples
David Scheim, Colleen Aldous, Barbara Osimani et al. (5 authors)
Journal of Clinical Medicine
Open Access
Published: May 2023
4 citations
4 citations
597 days before retraction
Acute COVID-19 Management in Heart Failure Patients: A Specific Setting Requiring Detailed Inpatient and Outpatient Hospital Care
Alberto Palazzuoli, Matteo Beltrami, Peter A. McCullough
Biomedicines
Open Access
Published: Mar 2023
5 citations
5 citations
675 days before retraction
Ivermectin - an antiviral drug for the COVID-19 pandemic?
Christopher Peterson, Anusha Ammu, Audrey Mangwiro et al. (4 authors)
The Southwest Respiratory and Critical Care Chronicles
Open Access
Published: Jan 2023
1 citation
1 citation
716 days before retraction
The Clinical Application of Ivermectin in COVID-19
土玲 车
Open Journal of Natural Science
Published: Jan 2023
739 days before retraction
The Place of Ivermectin in the Management of Covid-19: State of the Evidence
Babalola O.E, Ajayi A.A
Medical Research Archives
Open Access
Published: Jan 2023
739 days before retraction
SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects
Céline Boschi, David Scheim, Audrey Bancod et al. (8 authors)
International Journal of Molecular Sciences
Open Access
Published: Dec 2022
33 citations
33 citations
764 days before retraction
Letter in Reply: More Power To Ivermectin Multidrug Therapy
Sabine Hazan, Sonya Davé, Thomas J. Borody et al. (4 authors)
Future Microbiology
Published: Sep 2022
840 days before retraction
Comment on: ‘Effectiveness of Ivermectin-Based Multidrug Therapy in Severely Hypoxic, Ambulatory COVID-19 Patients’
Esmeralda Garza-Santiago, Alejandro Ortiz-Hernández, Ashuin Kammar‐García et al. (4 authors)
Future Microbiology
Published: Sep 2022
1 citation
1 citation
846 days before retraction
Changes in SpO2 on Room Air for 34 Severe COVID-19 Patients after Ivermectin-Based Combination Treatment: 62% Normalization within 24 Hours
Jaqueline C. Stone, Pisirai Ndarukwa, David Scheim et al. (7 authors)
Biologics
Open Access
Published: Aug 2022
11 citations
11 citations
862 days before retraction
Statistical Analysis Methods Applied to Early Outpatient COVID-19 Treatment Case Series Data
Eleftherios Gkioulekas, Peter A. McCullough, Vladimir Zelenko
COVID
Open Access
Published: Aug 2022
1 citation
1 citation
875 days before retraction
An anti-inflammatory and anti-fibrotic proprietary Chinese medicine nasal spray designated as Allergic Rhinitis Nose Drops (ARND) with potential to prevent SARS-CoV-2 coronavirus infection by targeting RBD (Delta)- angiotensin converting enzyme 2 (ACE2) binding
Ka Man Yip, Kwan Ming Lee, Tzi Bun Ng et al. (8 authors)
Chinese Medicine
Open Access
Published: Jul 2022
5 citations
5 citations
897 days before retraction
Systematic review and meta-analysis of ivermectin for treatment of COVID-19: evidence beyond the hype
Milena Soriano Marcolino, Karina Cardoso Meira, Nathália Sernizon Guimarães et al. (9 authors)
BMC Infectious Diseases
Open Access
Published: Jul 2022
33 citations
33 citations
901 days before retraction
Microbiome-Based Hypothesis on Ivermectin’s Mechanism in COVID-19: Ivermectin Feeds Bifidobacteria to Boost Immunity
Sabine Hazan
Frontiers in Microbiology
Open Access
Published: Jul 2022
1 citation
1 citation
913 days before retraction
Antiparasitic Drugs against SARS-CoV-2: A Comprehensive Literature Survey
Estefanía Calvo‐Álvarez, Maria Dolci, Federica Perego et al. (11 authors)
Microorganisms
Open Access
Published: Jun 2022
2 citations
2 citations
930 days before retraction
The drug used in Lim et al. 2022, source not specified, had &lt;1% incidence of AEs distinctive and common for ivermectin at this study’s very high dose, 2 mg/kg
David Scheim
Unknown Journal
Open Access
Published: May 2022
2 citations
2 citations
973 days before retraction
Nanovectorization of Ivermectin to avoid overdose of drugs
Éric Duverger, Guillaume Herlem, Fabien Picaud
Journal of Biomolecular Structure and Dynamics
Published: Apr 2022
989 days before retraction
A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at Its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and Antibody
David Scheim
International Journal of Molecular Sciences
Open Access
Published: Feb 2022
26 citations
26 citations
1049 days before retraction
Effectiveness of Ivermectin-Based Multidrug Therapy in Severely Hypoxic, Ambulatory COVID-19 Patients
Sabine Hazan, Sonya Davé, Anoja W. Gunaratne et al. (7 authors)
Future Microbiology
Open Access
Published: Feb 2022
27 citations
27 citations
1065 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #61082
Jun 13, 2022Quick Stats
Total Citations:
28
Years Since Retraction:
<1 year
Open Access:
Yes
Last Checked:
Jul 24, 2025